American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: Executive summary

Endocrine Practice

Volumn 22, Issue 7, 2016, Pages 842-884

  Garvey, W Timothy ^a   Mechanick, Jeffrey I ^b   Brett, Elise M ^b   Garber, Alan J ^c   Hurley, Daniel L ^d   Jastreboff, Ania M ^e   Nadolsky, Karl ^f   Pessah Pollack, Rachel ^b,g   Plodkowski, Raymond ^h   Bacha, Fida ⁱ   Bohannon, Nancy ^j   Bray, George A ^k   Bush, Michael A ^l   Caldarella, Felice ^m   Cobin, Rhoda ^b   Einhorn, Daniel ⁿ   Fujioka, Ken ^h   Gonzalez Campoy, J Michael ^o   Handelsman Md, Yehuda ^p   Henry, Robert R ^q   McGill, Janet B ^r   McKenzie, Travis ^d   Moghissi, Etie S ^s   Rubino, Domenica M ^t   Ryan, Donna H ^u   Wimalawansa, Sunil ^v   Zangeneh, Farhad ^w   more..

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g ProHEALTH Care Associates LLP   (United States)

^h SCRIPPS CLINIC   (United States)

ⁱ TEXAS CHILDREN S HOSPITAL   (United States)

^j MONTEFIORE MEDICAL CENTER   (United States)

^k LOUISIANA STATE UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m Center for Endocrine Health   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o Minnesota Center for Obesity Metabolism and Endocrinology   (United States)

^p Metabolic Institute of America   (United States)

^q UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^r WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t Washington Center for Weight Management and Research   (United States)

^u PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^v Cardio Metabolic Institute   (United States)

^w Vet Aff Med Ctr Dept Med T   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIRAGLUTIDE; NALTREXONE; TETRAHYDROLIPSTATIN;

ALCOHOLISM; ANTHROPOMETRY; ANXIETY; ASTHMA; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL PROTOCOL; CLINICAL RESEARCH; DEPRESSION; DYSLIPIDEMIA; ENDOCRINOLOGIST; EVIDENCE BASED PRACTICE; FEMALE INFERTILITY; GASTROESOPHAGEAL REFLUX; GLAUCOMA; HUMAN; HYPERTENSION; HYPOGONADISM; IMPAIRED GLUCOSE TOLERANCE; MEDICAL CARE; METABOLIC SYNDROME X; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OSTEOARTHRITIS; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; REVIEW; SLEEP DISORDERED BREATHING; STRESS INCONTINENCE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ENDOCRINOLOGY; HEALTH CARE QUALITY; LIFESTYLE; PERSONALIZED MEDICINE; PSYCHOLOGY; QUALITY OF LIFE;

ENDOCRINOLOGISTS; ENDOCRINOLOGY; HUMANS; LIFE STYLE; OBESITY; PRACTICE GUIDELINES AS TOPIC; PRECISION MEDICINE; QUALITY OF HEALTH CARE; QUALITY OF LIFE;

EID: 84999705794     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP161356.ESGL     Document Type: Review

References (75)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-497. [EL 3; SS]
2. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557-567. [EL 2; MNRCT]
3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806-814. [EL 3; CSS]
4. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307(5):483-490. [EL 3; SS]
5. Skinner AC, Skelton JA. Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. JAMA Pediatr. 2014;168(6):561-566. [EL 3; SS]
6. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012; 31(1):219-230. [EL 3; SS]
7. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008;16(10):2323-2330. [EL 3; SS]
8. Garvey WT. New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach. Endocr Pract. 2013;19(5): 864-874. [EL 4; NE]
9. Apovian CM, Garvey WT, Ryan DH. Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies. Obesity. 2015;23(Suppl 2):S1-S26. [EL 4; NE]
10. Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care editors' expert forum. Diabetes Care. 2015;38(8):1567-1582. [EL 4; NE]
11. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient - 2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013;19(2): 337-372. [EL 4; NE]
12. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract. 2012;18(5):642-648. [EL 4; NE]
13. American Medical Association. H440.842 Recognition of Obesity as a Disease. 2013. Available at: https://www.amaassn. org/ssl3/ecomm/PolicyFinderForm.pl?site=www.amaassn. org&uri=/resources/html/PolicyFinder/policyfiles/HnE/H-440.842.HTM. [EL 4; NE]
14. Garvey WT, Garber AJ, Mechanick JI, et al. American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on obesity: building an evidence base for comprehensive action. Endocr Pract. 2014;20(9):956-976. [EL 4; NE]
15. Garvey WT, Garber AJ, Mechanick JI, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014;20(9):977-989. [EL 4; NE]
16. Pi-Sunyer FX, Becker DM, Bouchard C and NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The Practical Guide: Identification, Evaluation and Treatment of Overweight and Obesity in Adults. National Institutes of Health publication number 00-4084. U.S. Department of Health and Human Services; 2000. Available at: http://www.nhlbi.nih.gov/files/docs/guidelines/prctgd-c.pdf. Accessed January 16, 2016. [EL 4; NE]
17. Colman E. Food and Drug Administration's Obesity Drug Guidance Document: a short history. Circulation. 2012; 125(17):2156-2164. [EL 4; NE]
18. Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American Association of Clinical Endocrinologists and American College of Endocrinology-clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015. Endocr Pract. 2015;21(Suppl 1):S1-S87. [EL 4; NE]
19. Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015;21(4):438-447. [EL 4; NE]
20. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985-3023. [EL 4; NE]
21. Seger JC, Horn DB, Westman EC, et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians. Available at: www.obesityalgorithm.org. Obesity Medicine Association. 2015. Accessed October 25, 2015. [EL 4; NE]
22. Apovian CM, Aronne LJ, Bessesen DH, et al. Endocrine Society. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362. [EL 4; NE]
23. Mechanick JI, Bergman DA, Braithwaite SS, Palumbo PJ. American Association of Clinical Endocrinologists Ad Hoc Task Force for Standardized Production of Clinical Practice Guidelines. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines. Endocr Pract. 2004;10(4):353-361. [EL 4; NE]
24. Mechanick JI, Camacho PM, Cobin RH, et al. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines - 2010 update. Endocr Pract. 2010;16(2):270-283. [EL 4; NE]
25. Mechanick JI, Camacho PM, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists-2014 Update and the AACe G4G Program. Endocr Pract. 2014;20(7):692-702. [EL 4; NE]
26. Gonzalez-Campoy JM, St Jeor ST, Castorino K, et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society: executive summary. Endocr Pract. 2013;19(5):875-887. [EL 4; NE]
27. Available at: http://www.cochranelibrary.com. [EL 4; NE]
28. Colberg SR, Albright AL, Blissmer BJ, et al. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc. 2010;42(12):2282-2303. [EL 4; NE]
29. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76-S99. [EL 4; NE]
30. Gonzalez-Campoy JM, St Jeor ST, Castorino K, et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society. Endocr Pract. 2013;19(Suppl 3): S1-S82. [EL 4; NE]
31. World Health Organization (WHO). Report of a WHO Consultation on Obesity. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization; 1997. Available at: http://whqlibdoc.who.int/hq/1998/WHO-NUT-NCD-98.1-(p1-158).pdf. [EL 4; NE]
32. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. [EL 4; NE]
33. Gardner CD, Kim S, Bersamin A, et al. Micronutrient quality of weight-loss diets that focus on macronutrients: results from the A TO Z study. Am J Clin Nutr. 2010;92(2):304-312. [EL 1; RCT]
34. Buscemi S, Cosentino L, Rosafio G, et al. Effects of hypocaloric diets with different glycemic indexes on endothelial function and glycemic variability in overweight and in obese adult patients at increased cardiovascular risk. Clin Nutr. 2013;32(3):346-352. [EL 1; RCT]
35. Rizkalla SW, Prifti E, Cotillard A, et al. Differential effects of macronutrient content in 2 energy-restricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial. Am J Clin Nutr. 2012;95(1):49-63. [EL 1; RCT, small N = 13]
36. Ebbeling CB, Swain JF, Feldman HA, et al. Effects of dietary composition on energy expenditure during weightloss maintenance. JAMA. 2012;307(24):2627-2634. [EL 1; RCT]
37. Foreyt JP, Salas-Salvado J, Caballero B, et al. Weightreducing diets: are there any differences? Nutr Rev. 2009(67 Suppl 1):S99-S101. [EL 4; NE]
38. Frisch S, Zittermann A, Berthold HK, et al. A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol. 2009;8:36. [EL 1; RCT]
39. Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab. 2010;12(3):204-209. [EL 1; RCT]
40. Tirosh A, Golan R, Harman-Boehm I, et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care. 2013;36(8):2225-2232. [EL 1; RCT]
41. Gadgil MD, Appel LJ, Yeung E, Anderson CA, Sacks FM, Miller ER 3rd. The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care. 2013;36(5):1132-1137. [EL 1; RCT]
42. Kerksick CM, Wismann-Bunn J, Fogt D, et al. Changes in weight loss, body composition and cardiovascular disease risk after altering macronutrient distributions during a regular exercise program in obese women. Nutr J. 2010;9:59-77. [EL 1; RCT]
43. Kerksick C, Thomas A, Campbell B, et al. Effects of a popular exercise and weight loss program on weight loss, body composition, energy expenditure and health in obese women. Nutr Metab. 2009;6:23. [EL 1; RCT]
44. McLaughlin T, Carter S, Lamendola C, et al. Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. Am J Clin Nutr. 2006;84(4): 813-821. [EL 1; RCT]
45. Muzio F, Mondazzi L, Harris WS, Sommariva D, Branchi A. Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. Am J Clin Nutr. 2007;86(4):946-951. [EL 1; RCT]
46. Summer SS, Brehm BJ, Benoit SC, D'Alessio DA. Adiponectin changes in relation to the macronutrient composition of a weight-loss diet. Obesity (Silver Spring). 2011; 19(11):2198-2204. [EL 1; RCT]
47. Bradley U, Spence M, Courtney CH, et al. Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial. Diabetes. 2009;58(12):2741-2748. [EL 1; RCT]
48. Brooking LA, Williams SM, Mann JI. Effects of macronutrient composition of the diet on body fat in indigenous people at high risk of type 2 diabetes. Diabetes Res Clin Pract. 2012;96(1):40-46. [EL 1; RCT]
49. Delbridge EA, Prendergast LA, Pritchard JE, Proietto J. One-year weight maintenance after significant weight loss in healthy overweight and obese subjects: does diet composition matter? Am J Clin Nutr. 2009;90(5):1203-1214. [EL 1; RCT]
50. Lim SS, Noakes M, Keogh JB, Clifton PM. Long-term effects of a low carbohydrate, low fat or high unsaturated fat diet compared to a no-intervention control. Nutr Metab Cardiovasc Dis. 2010;20(8):599-607. [EL 1; RCT]
51. Lopez-Legarrea P, de la Iglesia R, Abete I, Navas-Carretero S, Martinez JA, Zulet MA. The protein type within a hypocaloric diet affects obesity-related inflammation: the RESMENA project. Nutrition. 2014;30(4):424-429. [EL 1; RCT]
52. Cheng HL, Griffin H, Claes BE, et al. Influence of dietary macronutrient composition on eating behaviour and self-perception in young women undergoing weight management. Eat Weight Disord. 2014;19(2):241-247. [EL 1; RCT]
53. Tang M, Armstrong CL, Leidy HJ, Campbell WW. Normal vs. high-protein weight loss diets in men: effects on body composition and indices of metabolic syndrome. Obesity (Silver Spring). 2013;21(3):E204-E210. [EL 1; RCT]
54. Lasker DA, Evans EM, Layman DK. Moderate carbohydrate, moderate protein weight loss diet reduces cardiovascular disease risk compared to high carbohydrate, low protein diet in obese adults: a randomized clinical trial. Nutr Metab (Lond). 2008;5:30. [EL 1; RCT]
55. Tapsell L, Batterham M, Huang XF, et al. Short term effects of energy restriction and dietary fat sub-type on weight loss and disease risk factors. Nutr Metab Cardiovasc Dis. 2010;20(5):317-325. [EL 1; RCT]
56. Tapsell LC, Batterham MJ, Teuss G, et al. Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur J Clin Nutr. 2009;63(8):1008-1015. [EL 1; RCT]
57. Mohammad MA, Sunehag AL, Haymond MW. Effect of dietary macronutrient composition under moderate hypocaloric intake on maternal adaptation during lactation. Am J Clin Nutr. 2009;89(6):1821-1827. [EL 2; PCS]
58. de Souza RJ, Bray GA, Carey VJ, et al. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr. 2012;95(3):614-625. [EL 1; RCT, post-hoc analysis]
59. Buckland G, González CA, Agudo A, et al. Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study. Am J Epidemiol. 2009;170(12):1518-1529. [EL 2; PCS, post-hoc analysis]
60. Babio N, Toledo E, Estruch R, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ. 2014;186(17):E649-E657. [EL 1; RCT, secondary analysis]
61. Richard C, Couture P, Desroches S, Lamarche B. Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome. Obesity (Silver Spring). 2013;21(1):51-57. [EL 2; PCS]
62. Ryan MC, Itsiopoulos C, Thodis T, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138-143. [EL 1; RCT]
63. Stendell-Hollis NR, Thompson PA, West JL, Wertheim BC, Thomson CA. A comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women. J Womens Health (Larchmt). 2013;22(1):48-57. [EL 1; RCT]
64. Di Daniele N, Petramala L, Di Renzo L, et al. Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome. Acta Diabetol. 2013;50(3):409-416. [EL 2; PCS]
65. Richard C, Couture P, Desroches S, et al. Effect of the Mediterranean diet with and without weight loss on surrogate markers of cholesterol homeostasis in men with the metabolic syndrome. Br J Nutr. 2012;107(5):705-711. [EL 2; PCS]
66. Shai I, Spence JD, Schwarzfuchs D, et al. Dietary intervention to reverse carotid atherosclerosis. Circulation. 2010; 121(10):1200-1208. [EL 1; RCT]
67. Greenway FL, Fujioka K, Plodkowski RA, et al. COR-I Study Group. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595-605. [EL 1; RCT]
68. Pi-Sunyer X, Astrup A, Fujioka K, et al. SCALE Obesity and Prediabetes NN8022-1839 Study Group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11-22. [EL 1; RCT]
69. Fidler MC, Sanchez M, Raether B, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067-3077. [EL 1; RCT]
70. Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med. 2000;9(2):160-167. [EL 1; RCT]
71. Gadde KM, Allison DB, Ryan DH, et al. Effects of lowdose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341-1352. [EL 1; RCT]
72. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness, parts 1 and 2. JAMA. 2002;288:1775-1779, 1909-1914.
73. Barr VJ, Robinson S, Marin-Link B, et al. The expanded chronic care model: an integration of concepts and strategies from population health promotion and the chronic care model. Hosp Q. 2003;7:73-82.
74. Bodenheimer T, Willard-Grace R. The chronic care model and the transformation of primary care. In: Mechanick JI, Kushner RF, eds. Lifestyle Medicine: A Manual for Clinical Practice. New York, NY: Springer International; 2016: 89-96.
75. Bodenheimer T, Ghorob A, Willard-Grace R, Grumbach K. The 10 building blocks of high-performing primary care. Ann Fam Med. 2014;12:166-171.